Celgene and Bluebird Bio find results in treating patients with multiple myeloma. » Read More
By: Angelica LaVito
CEO Nick Leschly said Bluebird is cautious about calling its drugs cures, though it's "definitely a potential." » Read More
By: Dan Mangan
The Food and Drug Administration has issued just three warning letters over drug ads in 2017, down from 11 in 2016. » Read More
By: Craig Garthwaite, professor at Kellogg School of Management at Northwestern University
Given the cost of employer-provided insurance, the GOP should address a major source of economic inefficiency, Craig Garthwaite says. » Read More
Ascension Health and Providence St. Joseph Health are in talks about a merger between the two non-profits that would create the largest U.S. hospital chain.
Thanks to earlier detection, improved screening and innovative treatments, certain types of cancer are becoming more manageable than before.
Ascension Health and Providence St. Joseph are in merger talks athat would create the largest U.S. hospital chain, according to a report.
At-home genetic tests are expected to be a top purchase this holiday season. But be careful what you wish for.
Jim Cramer asked investors to be prepared for market volatility going into a week with bitcoin, tech and taxes front and center.
A number of states are on the verge of running out of their reserves of funding for the program by the end of the month.
Sage Therapeutics CEO Jeff Jonas hopes a drug in development for major depressive disorder will be as big as Prozac.
A Senate version of the tax bill would repeal Obamacare's rule requiring most Americans to have health insurance or pay a fine.
The FDA is figuring out how it will regulate software that helps doctors make treatment decisions.
Congress is considering tax legislation that could repeal the requirement that most Americans have health insurance or pay a fine.
Former Medtronic CEO Bill George says innovation is essential to improving the health of Americans, while cutting costs by improving system efficiency.
Demi Lovato is among investors backing Quip, an electric toothbrush start-up that is poised to hit the 1-million-customer mark next year.
Apple health group dierctor Anil Sethi is leaving to found a new start-up, Ciitizen.
Millennials are finding the new rules of consumer-driven health care tough to navigate.
German multinational Merck's life science and performance materials units help Chinese companies become more competitive.
Jim Cramer discussed the top 10 factors that weigh on him as he tries to make you money going into the new year.
Get the best of CNBC in your inbox